Karyopharm Therapeutics Inc
(FRA:25K)
€
0.8862
0.0364 (4.28%)
Market Cap: 115.58 Mil
Enterprise Value: 141.61 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 66/100 - Q1 2024 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 08, 2024€1.06 (+3.41%)Earnings
- Q4 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 29, 2024€1.06 (-15.69%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2023€0.7496 (-6.25%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Karyopharm Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Q2 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 02, 2023€1.51 (-7.77%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 04, 2023€2.62 (-18.49%)Earnings
- Karyopharm Therapeutics Inc to Host Investor Webcast on Selinexor Data in Patients with Treatment-Naive Myelofibrosis at AACR 2023 TranscriptApr 18, 2023
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 15, 2023€3.38 (+9.09%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Karyopharm Therapeutics Inc Investor and Analyst Event at ASH TranscriptDec 12, 2022
- Q3 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2022€4.59 (-0.69%)Earnings
- Karyopharm Therapeutics Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2022
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2022€4.77 (+3.82%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Karyopharm Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2022€5.9 (-0.10%)Earnings
- Karyopharm Therapeutics Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- Karyopharm Therapeutics Inc SIENDO Study Results Call TranscriptMar 17, 2022
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Karyopharm Therapeutics Inc Earnings, 2022 Financial Outlook and SIENDO Topline Results Discussion Call TranscriptFeb 08, 2022
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Karyopharm Therapeutics Inc Virtual Investor Day TranscriptDec 08, 2021
- Karyopharm Therapeutics Inc at Jefferies London Healthcare Conference (Virtual) - On-Demand TranscriptNov 18, 2021
- Q3 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2021€6.9 (+38.83%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Karyopharm Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) - Pre-Recorded TranscriptSep 13, 2021
- Q2 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 05, 2021€4.98 (-25.77%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2021
- Q1 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 03, 2021€7.45 (-5.67%)Earnings
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 11, 2021€12.96 (-1.97%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Karyopharm Therapeutics Inc - Karyopharm XPOVIO® FDA Approval in Multiple Myeloma Conference Call TranscriptDec 18, 2020
- Karyopharm Therapeutics Inc - Investor And Analyst ASH Event (Virtual) TranscriptDec 08, 2020
- Karyopharm Therapeutics Inc - Phase 3 SEAL Top-Line Results Conference Call TranscriptNov 20, 2020
- Karyopharm Therapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2020€12.39 (-4.84%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2020€13.49 (-2.95%)Earnings
- Karyopharm Therapeutics Inc to Discuss The FDA's Approval Of XPOVIO TranscriptJun 22, 2020
- Karyopharm Therapeutics Inc BOSTON Data Conference Call TranscriptMay 29, 2020
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Karyopharm Therapeutics Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2020€18.9 (+8.00%)Earnings
- Karyopharm Therapeutics Inc - Discuss Selinexor As A Potential Treatment For Hospitalized Patients With COVID-19 TranscriptApr 07, 2020
- Karyopharm Therapeutics Inc. Phase 3 BOSTON Study Top-line Results Conference Call TranscriptMar 02, 2020
- Q4 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 13, 2020€15.1 (-3.82%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 04, 2019€12.3 (+18.27%)Earnings
- Q2 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 06, 2019€6.87 (-5.63%)Earnings
- Karyopharm Therapeutics Inc Corporate Call TranscriptJul 03, 2019
- Karyopharm Therapeutics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Q1 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 09, 2019€4.12 (-2.60%)Earnings
- Q4 2018 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 28, 2019€3.7 (-6.33%)Earnings
Karyopharm Therapeutics Inc at RBC Global Healthcare Conference (Virtual) Transcript
May 19, 2020 / 12:35PM GMT
Release Date Price:
€16.1
(-9.04%)
Brian Corey Abrahams
RBC Capital Markets, Research Division - Senior Biotechnology Analyst
Good morning, everyone. I'm Brian Abrahams, senior biotech analyst at RBC Capital Markets. Thanks, again, for joining us. Our next featured company is Karyopharm, represented by their CEO, Michael Kauffman; their CFO, Mike Mason; as well as Ian Karp, their VP of Investor and Public Relations. Thanks very much, guys, for joining us.
Michael G. Kauffman
Karyopharm Therapeutics Inc. - Co-Founder, CEO & Director
Great to be here. Thanks, Brian.
Questions & Answers
Brian Corey Abrahams
RBC Capital Markets, Research Division - Senior Biotechnology Analyst
So maybe just kicking off on the clinical side. We're going to be seeing some data upcoming from your positive Phase III BOSTON study at ASCO in just a few weeks. Can you tell us a little bit about what we should be looking for out of XPOVIO in this data? And what you think is going to be most useful for physicians to determine how to best use the agent, coming out
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)